News
)
14 November 2019
VIVEbiotech participates in the Bio-Europe fair in Hamburg
VIVEbiotech participated in the Bio-Europe conference that took place in Hamburg, Germany, on November 11, 12 and 13. Bio-Europe is an international partnering conference, and this year its 2...
Read more)
28 October 2019
Barcelona hosts the 27th annual congress of the ESGCT
The 27th annual congress of the ESGCT, the European Society of Gene and Cell Therapy, was held in Barcelona from October 22 to 25.
Read more)
14 October 2019
VIVEbiotech and VIRALGEN organize the I Symposium on Gene Therapy Manufacturing
VIVEbiotech and VIRALGEN, specialized in the production of viral vectors for gene therapy, have organized the I Symposium on Gene Therapy Manufacturing, a meeting that...
Read more)
7 October 2019
VIVEbiotech participates in two international congresses specialized in gene therapy
VIVEbiotech has participated in two international conferences specialized in gene therapy in the months of September and October of this year.
Read more)
23 September 2019
VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
VIVEbiotech has carried out a capital increase of 3.5 million euros to finance its strategic plan, which highlights the construction of three new cleanrooms and the...
Read more)
6 September 2019
The Minister of Health visits VIVEbiotech
The Minister of Health, María Luisa Carcedo, has visited VIVEbiotech.
Read more)
20 June 2019
VIVEbiotech joins the #juntosporedaravet campaign organized by the Apoyodravet association
VIVEbiotech has joined the #juntosporeldravet campaign organized by the Apoyodravet association this week, coinciding with the International Dravet Syndrome Awareness Day. As they told us...
Read more)
13 June 2019
VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office
VIVEbiotech, a company specialized in the production of lentiviral vectors for their use in gene therapy, has received notification of the patent grant for the...
Read more)
24 May 2019
VIVEbiotech participa en el World Advanced Therapies and Regenerative Medicine Congress en Londres
El World Advanced Therapies and Regenerative Congress tuvo lugar en el Business Design Centre de Londres del 15 al 17 de mayo.
Read more)
14 May 2019
VIVEbiotech participates in two conferences last April
VIVEbiotech has participated in two international conferences this past April.
Read moreDestacadas
)
)
)
)
){kind=spacer}
4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
)
)
14 February 2024
VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024
)
)
9 February 2024
)